Stay updated with breaking news from Singulex Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marketresearch.biz reports that the The global Personalized Medicine Biomarkers Market was valued at USD 15.5 Billion in 2022. It is expected to reach USD 67.6 Billion by 2032, with a CAGR of 16.3% during the forecast period from 2023 to 2032.Overview of the Personalized Medicine Biomarkers MarketThe Personalized Me...
/PRNewswire/ -- Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at...
/PRNewswire/ -- In the world of healthcare diagnostics, the Clostridium Diagnostics Market is poised for substantial growth, driven by a convergence of factors...
/PRNewswire/ -- The "Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...
/PRNewswire/ -- The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering. The 16th edition...